Multiple sclerosis (MS) is one of the leading causes of disability and many efforts have been implemented to help expedite diagnosis and initiate early effective treatment. With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of MS, such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis. In this supplement, these topics will be addressed along with recognizing treatment failure, knowing when to switch therapies, and how to incorporate patient preference in treatment-related decisions
Upon completion of this activity, participants should be better able to:
Professor and Vice Chair, Clinical Affairs
Department of Neurology
Director, MS Comprehensive Care Center
Stony Brook University Hospital
Stony Brook, NY
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources